1Cordon-Cardo C,Wartinger M,Melameo M,et al. Immunopathology analysis of human urinary bladder cancer[J]. Am J pathol,1992,140(2) :375-385.
2Fradet Y,Gauthier J,Bedard G,et al. Monitoring and prognostic determination of bladder tumors by flow cytometry with monoclonal antibodies on bladder irrigations [J]. J Urol, 1991,145: 250-255.
3Lodde M,Mian C,Pycha A,et al. Immunocyt for the detection of transitional cell cancer of the urinary tract [J]. J Urol, 1999,161:150-154.
4Sarosdy MF, De-Vere-White RW, Soloway MS, et al. Results of a multicenter trial using the BTA-test to monitor for and diagnose recurrent bladder cancer[J]. J Urol, 1995,154(2) :379-384.
5Pode D,Shapiro a,Wald M, et al. Noninvasive detection of bladder cancer with the BTA stat test[J]. J Urol, 1999,161(2) :443-446.
6Carpinito GA,Stadler WM,Briggman JV,et al. Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract[J]. J Urol,1996,156(4): 1280-1285.
7Itzkowitz SH,Yuan M,Fukushi Y,et al. Lewis X and sialyated Le X related antigen expression in human malignant and nonmalignant colonic tissues[J]. Cancer Res, 1986,46(10) :2627-2631.
8Sheinfeld J,Reuter VE,Melamed MR,et al. Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation[J]. J Urol, 1990,143 (2): 285-288.
9Pode D, Golijanin A, Sherman, et al. Immunostaining of Lewis X in cells from voided urine,cytopathology and ultrasound for noninvasive detection of bladder tumors[J]. J Urol, 1998,159 (2) :389-393.
10Monier F,Surla A,Guillot M,et al. Gelatinase isoforms in urine from bladder cancer patients[J]. Clin Chim Acta,2000,299(1～2) :11-23.
